UnitedHealth Group Incorporated $UNH Stock: Left Brain Wealth Management LLC Boosts Position

Key Points

• Left Brain Wealth Management increased its UnitedHealth position by 480.4% in the third quarter, bringing its holdings to 5,816 shares valued at approximately $2.14 million. Institutional investors and hedge funds collectively own 87.86% of the company.
• UnitedHealth reported quarterly EPS of $4.69, beating estimates of $4.14, while revenue reached $112.70 billion versus the $111.31 billion consensus. The company issued FY2026 guidance of approximately $20.50 EPS.
• The company maintains a quarterly dividend of $2.32 per share, equivalent to a 2.3% yield, while analysts collectively rate the stock “Moderate Buy” with an average price target of $463.93.

Left Brain Wealth Management LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 480.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,816 shares of the healthcare conglomerate's stock after purchasing an additional 4,814 shares during the period. Left Brain Wealth Management LLC's holdings in UnitedHealth Group were worth $2,135,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. General Partner Inc. acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $512,000. PBCay One RSC Ltd acquired a new stake in UnitedHealth Group during the first quarter worth about $14,343,000. Lee Johnson Capital Management LLC acquired a new stake in UnitedHealth Group during the second quarter worth about $6,180,000. Kinsale Capital Group Inc. raised its position in UnitedHealth Group by 13.4% during the second quarter. Kinsale Capital Group Inc. now owns 38,510 shares of the healthcare conglomerate's stock valued at $16,006,000 after acquiring an additional 4,557 shares in the last quarter. Finally, Fideuram Intesa Sanpaolo Private Banking S.P.A. lifted its holdings in UnitedHealth Group by 1,287.2% in the first quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. now owns 60,022 shares of the healthcare conglomerate's stock valued at $16,241,000 after acquiring an additional 55,695 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Down 1.0%

UnitedHealth Group stock opened at $406.67 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.78. The stock has a market capitalization of $365.02 billion, a PE ratio of 23.23, a price-to-earnings-growth ratio of 1.49 and a beta of 0.60. The business has a 50 day simple moving average of $390.20 and a 200-day simple moving average of $362.40. UnitedHealth Group Incorporated has a 12 month low of $255.96 and a 12 month high of $461.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The firm had revenue of $112.70 billion for the quarter, compared to analyst estimates of $111.31 billion. During the same quarter last year, the firm posted $2.59 EPS. The business's revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were issued a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group's dividend payout ratio (DPR) is presently 53.00%.

Insider Activity

In other news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.19% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several equities research analysts have commented on the company. UBS Group restated an "outperform" rating on shares of UnitedHealth Group in a research report on Tuesday, October 13th. Sanford C. Bernstein cut their target price on shares of UnitedHealth Group from $512.00 to $500.00 and set an "outperform" rating for the company in a report on Wednesday, October 14th. Barclays decreased their target price on shares of UnitedHealth Group from $441.00 to $440.00 and set an "overweight" rating for the company in a research note on Wednesday, October 14th. Weiss Ratings raised shares of UnitedHealth Group from a "hold (c-)" rating to a "hold (c)" rating in a report on Thursday, October 8th. Finally, Wall Street Zen upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Saturday, August 8th. Twenty investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of "Moderate Buy" and an average price target of $463.93.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Improving margins and higher price target: Morgan Stanley said UnitedHealth’s margins are recovering, with Medicare operations returning to a more normal range, and raised its price target. However, commercial insurance, Medicaid and increased AI-related spending remain important execution tests. UnitedHealth is bouncing back, but a major risk remains
• Positive Sentiment: Recent earnings beat and raised guidance: UnitedHealth’s latest quarterly results exceeded expectations for both earnings and revenue, and the company raised its outlook. The earnings recovery supports the case that operating performance is stabilizing after earlier pressure. Why Did UnitedHealth Raise Guidance After Its Quarterly Beat?
• Positive Sentiment: Dividend appeal: UnitedHealth is highlighted as a major healthcare dividend payer, potentially supporting demand from income-focused investors. The article also cautions that dividend safety should be assessed alongside payout sustainability and business risks. $250,000 in Merck, Pfizer, UnitedHealth and AbbVie Could Pay $8,000 a Year in Dividends
• Neutral Sentiment: Analyst estimates are mixed: Zacks Research maintained a “Hold” rating and projects roughly $20.54 in FY2026 EPS, close to the broader consensus near $20.62. It raised several longer-term quarterly estimates but lowered others, including Q1 2027, Q1 2028 and Q2 2028.
• Negative Sentiment: Near-term earnings pressure: Zacks Research issued a negative estimate for fourth-quarter earnings, adding to concerns that high medical utilization and costs could limit profitability despite the Medicare recovery. Zacks Research Has Negative Estimate for UNH Q4 Earnings

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.